Various methods have been used to estimate cytotoxicity in mammalian cell genotoxicity assays since their introduction more than four decades ago, and although there is no agreement on whether any single method is optimal, there is now a better appreciation of their limitations. Methods based on aspects of cellular function are inevitably inaccurate unless some estimate of cell number is included, and those using some measure of cell proliferation give different results depending on the mathematical model used. Although it would be desirable, it is not possible to provide a universal measure of cytotoxicity because the phenomenon is so complex. There is some flexibility in the limits of cytotoxicity proposed in regulatory guidelines, and it can be argued these could be even less precise. Also, to make valid comparisons of the performance of different test systems, novel or established, it would seem essential to use similar measures of cytotoxicity.
Methods used to determine cytotoxicity in various assays
All current international guidelines for the conduct of mammalian cell genotoxicity assays require that compounds are tested to the prescribed maximum concentrations, the limit of solubility in delivering solvent or tissue culture medium or the highest level allowed by cytotoxicity. It is recognised that excessively toxic concentrations can lead to problems with data interpretation or may cause artefactual positive results (1-3), but there is no consistency on how to define excessive toxicity in the various different assays. Although cytotoxicity methods are defined in the Organization for Economic Cooperation and Development (OECD) and International Conference on Harmonisation (ICH) guidelines for in vitro cell mutation, chromosome aberration and micronucleus tests (4) (5) (6) (7) (8) , they differ in both the end points to be measured and the maximum levels that must be achieved. For cell mutation tests, cytotoxicity can be measured either by relative cloning efficiency (CE) or relative total growth (RTG). Relative CE at the end of the treatment period is typically used for assays at the hprt locus in Chinese hamster cells (9, 10) and was the preferred method when the microtitre version of the mouse lymphoma tk assay (MLA) was introduced (11) . However, RTG was originally used for the agar cloning method (12) and was subsequently adopted as the standard method for the MLA using either agar or microtitre cloning (13) . For all cell mutation assays, reduction in survival to 10-20% of the control is required (5, 7) , although it is noted that, in the MLA, caution is appropriate in interpreting results when increases in mutation are seen only less than 20% RTG (8) . For chromosome aberration assays, cell number, confluency or mitotic index (MI) can be measured; originally, a reduction of any of these parameters by greater than 50% was required (4,7), but this has been slightly modified to "should not exceed a reduction of approximately 50%" for pharmaceuticals (8) . For in vitro cytogenetic assays, it has been argued that relative population doubling (RPD) gives a better estimate of cytotoxicity than simple comparisons of cell counts (14) for reasons that will be discussed later. For the in vitro micronucleus test, the recently published OECD guideline (6) recommends cytokinesis-block proliferation index (CBPI) or replicative index (RI) for protocols using cytochalasin B and RPD, relative increase in cell counts (RICC) or proliferation index for methods not using cytochalasin B. The highest concentration should aim to produce 55% ± 5% cytotoxicity, that is, 50-60% or slightly more than specified in ICH S2(R1) (8) . There is no published guideline for the in vitro comet assay but viability estimated by trypan blue (TB) exclusion with concentrations resulting in ≤30% TB-positive cells being analysed has been suggested (15) . More recently using TK6 cells, relative total levels of ATP and caspases 3-7 in control and treated cultures have been compared with cell numbers, and ≥80% ATP level and <1.5 induction of caspase are considered to equate to 50% reduction in relative cell count (RCC) (16) , although the relative values are influenced by the time of measurement.
The current mammalian cell genotoxicity assays were first introduced in the 1970s, and the methods to estimate cytotoxicity in them developed largely through practical convenience and personal preferences without any intention to give consistency between the different tests. For example, for cytogenetic assays, it was noted that chromosome aberrations are often found only at concentrations resulting in some cytotoxicity and that the highest level chosen should cause significant reduction in MI but not so great a reduction that insufficient cells can be found for chromosome analysis (17) . Because the methods in the various systems are so different, it is inevitable that the absolute levels of cytotoxicity that are achieved in them are also different even when the same nominal level, for example, 20% or 50% is attained. The reasons for these discrepancies are considered in the next section.
Theoretical time courses of response to different cytotoxic agents
The theoretical time courses of response to three agents exerting their cytotoxicity differently are illustrated in Figure 1 . The first agent (A) induces damage that results in some reduction in cell growth during the treatment period, which persists after it is removed so that the surviving cells continue to divide more slowly than the controls. Classic genotoxins are likely to behave in this way by inflicting permanent damage on DNA and other cellular macromolecules, and an example, 4-nitroquinoline-N-oxide (4-NQO), is illustrated later. The second agent (B) blocks cell division immediately or very quickly after administration and the cells remain nondividing but otherwise functionally normal until they die some considerable time, often days, later. Such agents include γ-irradiation and DNA cross-linking agents, and this effect has long been used to prepare feeder cells for the culture of many cell types (18) . However, it should be noted that at lower levels where cell division is not completely blocked, γ-irradiation and cross-linking agents behave as classic genotoxins with responses described for A. The third agent (C) is toxic to cells when present during the treatment period but has no lasting effect when it is removed, and the surviving cells continue to divide at the same rate as the controls. Any compound exerting its toxicity by direct action on the cell membrane, a detergent for example, might be expected to give this response. Spindle poisons represent another type of response (not illustrated) where division is arrested during treatment, but the cells are not killed and subsequently start to divide again.
These models are extreme and simplistic, but they do illustrate the point that the time at which any cytotoxicity estimate is made will influence the answer that is obtained. In these examples, toxicity as measured by cell number at the end of treatment is in the order A < B < C, but at some time t later it becomes C < A < B. The cytotoxic responses to real agents are inevitably more complex than these simple models, and like γ-irradiation or cross-linkers, the pattern of response may be different at different levels of toxicity, but they do highlight some important general observations relating to cytotoxicity determinations based on both cell function and cell numbers, and these are considered in the following sections. (A) An agent that is toxic to cells during the treatment period by accumulating damage that persists after it is removed. (B) An agent that blocks cell division during and after the treatment period but does not result in cell death until sometime later. (C) An agent that is toxic to cells during the treatment period but has no lasting effect on the rate of cell division of the survivors. Note that toxicity as measured by cell number is in the order A < B < C at the end of the treatment period but C < A < B at some time t later. 
Methods that estimate cytotoxicity by cellular function
The first point is that any method estimating cytotoxicity by any aspect of cellular function at or shortly after the end of treatment will, in nearly all cases, underestimate the absolute level of cytotoxicity because cells that have sustained damage that will eventually result in their death may remain fully functional for some considerable time. This is well illustrated by the responses to lethal doses of either γ-irradiation or mitomycin C (MMC) of mouse fibroblasts used to provide feeder cells to improve the growth of human B-lymphocytes in vitro (19) . Using propidium iodide and annexin V staining to measure apoptotic and necrotic cells, 96% of cells are viable 24 h after treatment with either agent, and 75-83% of cells are still viable after 4 days ( Figure 2 ). Further, although there is no replicative function indicated by 5-bromo-2'-deoxyuridine incorporation and all the cells will die some days later, mitochondrial function assessed by 3(4,5-dimethylthiazozyl-2)-2,5-diphenyltetrazolium bromide (MTT) reduction is normal in the γ-irradiated cells and still significantly greater than the control in those treated with MMC ( Figure 3 ). If cytotoxicity had been assessed by MTT reduction at the end of treatment, it would have been concluded that γ-irradiation had no, and MMC relatively little, effect on cell survival.
The limitation of measuring cellular function has long been appreciated and has been demonstrated for numerous methods and in various cell lines. More than 30 years ago, the exclusion of TB and erythrosin B immediately after treatment was shown to underestimate the cytotoxicity determined by CE of various agents in L1210 mouse leukaemia and DON Chinese hamster cells (20) . Further, differences were seen between the cell lines for the dye exclusion methods but not CE, and the presence of serum was found to inhibit staining of nonviable cells by TB. ATP levels were shown to underestimate the toxicity to CHO cells of adriamycin, 2,4-diaminotoluene and MMC in comparison with CE even when measured 24-29 h after the start of a 3 h treatment period (21) . The importance of the time at which cellular function is measured is particularly well illustrated by the response of the human osteogenic sarcoma cell line U-2OS to sodium arsenite (22) . Clonal survival, MTT reduction and neutral red (NR) exclusion were compared and correlated well only when the factor of time was taken into account. Both NR and MTT underestimated the toxicity at the end of a 24 h exposure period in comparison with clonal survival, and it was concluded that both should only be used after an interval of at least 48 h has elapsed after exposure to arsenite; other toxicants may also show similar delayed toxicity. The importance of time is further illustrated by the response of HepG2 cells to toxic concentrations of tamoxifen. No decrease in ATP content was seen immediately after treatment, but progressive decreases were seen up to 24 h (23). The reduction of a tetrazolium salt similar to MTT also indicated a progressive increase in toxicity with time, although high concentrations did have some immediate effect. It should be noted, however, that if nondividing cells are used, some aspect of cellular function is the only practicable method to estimate cytotoxicity, and both TB exclusion and ATP levels have been optimised for the rat hepatocyte alkaline elution assay (24) , although estimates are much more accurate if the cells are left to recover for 3 h after treatment (25) .
The second point is that if an aspect of cellular function is measured some time after the end of exposure to the test agent, cytotoxicity will be underestimated if the numbers of cells that were killed during and after treatment are not considered. Cytogenetic assays where MI is measured and micronucleus tests where CBPI or RI are the estimates of cytotoxicity typically do not count cell numbers in treated cultures or controls. The effect is illustrated in Table I , where relative suspension growth (RSG)/RCC is compared with MI for mouse lymphoma cells treated with 2,4-dinitrophenol; no effect on MI (measured 24 h after the start of treatment) is seen until RSG (measured 48 h after treatment) has been reduced to <10% (26) . In cultured lymphocytes, no reduction in RI was seen with concentrations of hycanthone, reducing survival to approximately 40-65% RSG (27) . In principle, the accuracy of estimates such as MI and RI should be improved if the control and treated cell numbers are also included in the calculation.
Methods that estimate cytotoxicity from cell numbers
The methods used to calculate cytotoxicity from cell numbers counted at various times after treatment, that is, RCC, RICC, RSG and RPD, are shown in Figure 4 and have been defined elsewhere (6, 12, 14, 28) . It should be noted that if the initial cell numbers are the same in both control and treated cultures (which is always the case except when intentionally examining responses at very low levels of survival), RCC is exactly the same as RSG so both are considered together here. Model data showing how RSG/RCC, RICC and RPD relate to each other in relation to cell population doublings are presented in Table II and in relation to cell numbers for a population doubling time typical of mouse lymphoma cells are shown in Table III . All of these examples assume that, at each time point, the increases in cell numbers are fixed at 50% and 20% of the control, that is, RICC is 50% and 20%, respectively, and the RSG/RCC and RPD values are calculated from them. This is intended to show only how the three estimates relate to each other with time, not that typical cell populations respond in this way to toxic insult or that RICC is necessarily the most appropriate measure.
It has been noted previously that RSG/RCC can be misleading (14) because if, for example, cultures are seeded with 0.5 × 10 6 cells and the control doubles to 1 × 10 6 during the experiment, a culture that does not grow at all would still have a cell count 50% of the control, that is, cytotoxicity according to RSG/RCC would be 50%. The underestimation of cytotoxicity by RCC in relation to RICC, RPD, CBPI and RI has also been illustrated (29) , and the limitation is apparent in all the examples here. It can be seen that the underestimate by RSG/RCC in comparison with RICC decreases with increasing cell numbers because the initial error becomes progressively smaller, and after four to five doublings they differ by only 2-3%. In contrast, cytotoxicity estimated by RPD progressively decreases in comparison with RICC, simply because it is the log comparison, best visualised in Figure 5 . Table III shows cell numbers for a culture with a population doubling time typical of mouse lymphoma cells and illustrates the fact that at any time point, the relative survival estimated by RSG/ RCC, RICC and RPD are different. From Tables II and III , it is obvious that ratios also differ when measured at the same time in cultures with different population doubling times; RSG/ RCC approaches and RPD progressively underestimates RICC more slowly in less rapidly dividing cultures. All of the above simply illustrate the important points (a) that the three different estimates of cytotoxicity all give different values from the same cell counts at any point in time, (b) that the same method will give different values at different time points and (c) that the same method applied at the same time to different cell types will give results determined by their population doubling times. Further, the model data considered previously make the assumptions that the control populations divide at the same rate throughout the relevant periods and that the increases in cell numbers are exactly 20% or 50% at each time point. In practice, the cell numbers in real cultures treated with toxic agents are much more complex, and an example using mouse lymphoma cells is presented in the following paragraphs.
Although RPD measured at approximately 1.5× the control cell cycle time after the start of treatment has been proposed as a better estimate of cytotoxicity than RSG/RCC for in vitro chromosome aberrations tests (14) , it has recently been suggested (30) that it may not be appropriate for in vitro micronucleus tests. As noted earlier, cytotoxicity estimated by RPD progressively decreases in comparison with RICC, and option B for the extended exposure period in the OECD guideline (6) suggests that cells should be treated for 1.5-2.0 normal cell cycles then harvested after a further 1.5-2.0 cycles. Therefore, RPD after 3-4 cell cycles could underestimate cytotoxicity and might result in excessively toxic concentrations being tested.
All the previously mentioned examples use mathematical models in which division rates are assumed to be same throughout the entire time course. However, the behaviour of real cell cultures is more complex, as shown by the response of mouse lymphoma cells to 4-NQO illustrated in Figure 6 and Table IV. In the control cultures, population doubling time is slowed in the first 24 h, presumably because of the manipulations associated with treatment and 3 h exposure in medium containing only 2.5% serum, and delayed cell progression due to treatment has also been noted for CHO cells (14) . The progressive increase in growth rate with time in the treated cultures is presumably because the population is heterogeneous, containing cells that have been damaged to different extents, and the doubling time decreases as more rapidly dividing subpopulations overtake more damaged, slowly dividing ones. Finally, it is noted that, after 48 h, RSG/RCC and RCC are very similar to each other, as predicted for the model data in Tables II and III because The mouse lymphoma assay also illustrates another factor in attempting to compare estimates of cytotoxicity in different test systems because the preferred measure, RTG, is the product of RSG/RCC and CE at the end of the expression period and the cloning period. RSG/RCC is by far the major component of RTG for most compounds because the increase in cell numbers is usually at least 16-fold, but the CE is seldom reduced by more than approximately 50%. For this reason, 48 h RSG/RCC is routinely used for screening tests with mouse lymphoma cells in this laboratory so that the same level of toxicity is achieved for Tk (12)), RPD as defined in Greenwood et al. (14) and CBPI and RI as defined in OECD 487 (6). mutation and micronucleus end points. However, for a smaller proportion of compounds such as MMC (Table V) , CE can have a marked effect on RTG. In this example, any of the methods looking only at cell number increase underestimate cytotoxicity by comparison with CE measured either at the end of treatment or at the end of the 48 h expression period as in RTG.
Concluding remarks
After four decades of experience, different mammalian cell genotoxicity assays still use various methods to measure cytotoxicity. There is no agreement on whether any single method is optimal, but there is now a better appreciation of their limitations and the reasons that they all give different answers.
The most important objective of limiting the maximum cytotoxicity to be achieved is to avoid artefactual results that may be obtained at very high levels, whether through the end point being affected by toxicity or the statistical power being limited by the target cell numbers being greatly reduced. For tests to be submitted to regulatory authorities, the cytotoxicity methods used will inevitably be defined by relevant guidelines, particularly ICH S2(R1) for pharmaceuticals, and although different methods are specified, these were designed to minimise artefactual results. Nevertheless, it is worthwhile to consider how the various methods may be used in different situations. As identified earlier, assays based on cell function at the end of the treatment period will underestimate cytotoxicity because cells that are still functional but have sustained lethal damage and will die some time later are recorded as viable. It has been shown that MTT reduction and NR exclusion can correlate well with CE but only at least 48 h after treatment (22) . The accuracy of cell function methods could probably be improved by making them some time after the end of treatment, but it would be just as easy to count the cell numbers and use an estimate such as RPD. Similarly, MI and RI used in cytogenetics and micronucleus tests underestimate cytotoxicity because they do not take into consideration cells that have died and disintegrated but, in principle, it should be possible to overcome this limitation simply by counting the cell numbers at the time MI or RI are estimated. 60%  40%  30%  25%  23%  21%  21%  20%  RICC  20%  20%  20%  20%  20%  20%  20%  20%  RPD  26%  34%  42%  50%  57%  63%  67%  71% a Calculated assuming the increase in cell numbers is 20%/50% of the control.
It can be argued that only CE at the end of the treatment period gives a definitive estimate of the proportion of treated cells that have survived treatment and could, in principle, continue to divide with heritable genetic change that might be relevant to the carcinogenic process. It is also unambiguous unlike other methods using cell proliferation where different estimates can be made from the same cell counts, for example, RICC compared with RPD. However, there is evidence that in at least some cell lines, growth at clonal density may be different from that in the mass cultures used for the actual genotoxicity tests. Although CE may be the best way to compare the relative sensitivities of genetic variants (31), it may not be as appropriate for assessing novel potentially genotoxic agents and is not likely to be adopted for routine use in all assays. Nevertheless, there is a widely held view that the most appropriate cytotoxicity methods are based on cell proliferation during and after treatment and that is provided by both RPD and RICC (or RTG for mouse lymphoma cells because, in most cases, it is very similar to RICC for the reasons identified previously). Also, although guidelines such as ICH S2(R1) specify different levels of cytotoxicity to be achieved by RPD and RTG/RICC, approximately 50% and 20%, respectively, because they are logarithmic and linear comparisons, they are actually very similar in many of cases.
The previously mentioned arguments can be applied to most established cell lines routinely used for genotoxicity testing, but there are other potentially valuable cell types that present different problems. Methods assessing proliferation obviously cannot be used for hepatocytes, but there is still no reason why cell function or numbers should not be made some time rather than immediately after treatment. Lymphocytes are also problematic, and the usual estimate of cytotoxicity in human whole blood cultures is MI, which often varies considerably between experiments even using blood from the same donors. Because phytohaemagglutinin stimulates only T-cells, in principle it should be possible to count CD3 cell numbers by flow cytometry in control and treated cultures and use them to adjust MI to give a better estimate of proliferation. However, despite some effort, a practicable solution has not been found in this laboratory, and the interaction between T-cell subsets in culture (32) may also present problems.
In conclusion, although it would be desirable, it is not possible to provide a universal measure of cytotoxicity because the phenomenon is so complex. For tests to be submitted to regulatory authorities, the methods are reasonably well defined and unlikely to change in the immediate future. Encouragingly, the methods based on cell proliferation, although apparently different, are actually quite similar in practice. There is some flexibility with 50-60% reduction in RPD being similar to 80-90% RTG in many cases, and there is little to be gained by attempting to define these limits any more accurately. There is increasing use of problem solving and higher throughput predictive screens, and particularly for the latter, it would seem sensible to use the same measure of cytotoxicity for different end points in the same cell line. For example, this laboratory performs comet, micronucleus and Tk assays in mouse lymphoma cells but uses the 48 h RSG to determine cytotoxicity for them all (33) . Further, to make valid comparisons of the performance of different test systems, novel or established, it would seem essential to use similar measures of cytotoxicity. Calculated using an estimated doubling time of 9.9 h (e.g. Figure 6 ). b Calculated assuming the increase in cell numbers is 20%/50% of the control. Figure 6 . a ×10 5 /ml cultures diluted to 1.5 × 10 5 /ml each day. 
